Piramal Pharma informs about analyst meet

04 Jun 2024 Evaluate
Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Piramal Pharma has informed that pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the schedule of Analyst or Institutional Investor Meetings with the Company as on 18th June, 2024.

The above information is a part of company’s filings submitted to BSE.

Piramal Pharma Share Price

135.70 2.65 (1.99%)
24-Mar-2026 14:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1761.60
Dr. Reddys Lab 1253.45
Cipla 1228.45
Zydus Lifesciences 887.45
Lupin 2332.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×